ADMA Biologics (ADMA)

ADMA Biologics (ADMA) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• ADMA last traded at $11.05, -3.11% on the day.
• ADMA Biologics: market cap $2.56B, P/E 15.4, revenue $512.27M over the last four quarters, next earnings 2026-11-04.
• Over the past year ADMA returned -27.60%; year to date -39.39%.

Updated 2026-11-02 23:10 UTC